PHBI – Pharmagreen Announces Affirmed MOU To Acquire Licensed California Cannabis Company
January 06, 2022 08:51 ET
|
Pharmagreen Biotech, Inc.
CARSON CITY, NV, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc., (OTCQB: PHBI), today announced an affirmed memorandum of understanding (MOU) to acquire Long Valley Farms LLC,...
PHBI Pharmagreen Announces Affirmed MOU to Acquire Licensed California Cannabis Company
January 06, 2022 08:00 ET
|
Pharmagreen Biotech Inc.
CARSON CITY, NV, Jan. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Pharmagreen Biotech, Inc., (OTCQB: PHBI), today announced an affirmed memorandum of understanding (MOU) to acquire Long Valley...
PHBI - Pharmagreen Biotech Announces Up-Listing To OTCQB Venture Market
December 21, 2021 10:05 ET
|
Pharmagreen Biotech Inc.
CARSON CITY, NV, Dec. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech Inc., (OTCQB: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD...
PHBI - Pharmagreen Biotech Announces Up-Listing To OTCQB Venture Market
December 20, 2021 09:23 ET
|
Pharmagreen Biotech, Inc.
CARSON CITY, NV, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Pharmagreen Biotech Inc., (OTCQB: PHBI), a specialized tissue cultured starter plantlet production company, targeting the CBD Hemp and Cannabis...
PHBI – Pharmagreen Previews Imminent Next Strategic Steps Advancing Its Proprietary Cannabis Tissue Culture Technology Into Recurring Revenue Generation
December 16, 2021 09:57 ET
|
Pharmagreen Biotech, Inc.
CARSON CITY, NV, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc., (OTC PINK: PHBI), today continued in the release of a series of management updates from CEO Peter Wojcik as the company...
PHBI – Pharmagreen Plans To Transition Cannabis Industry Economics Making Adoption Of Its Proprietary Plant Tissue Technology An Industry Standard
December 09, 2021 11:36 ET
|
Pharmagreen Biotech, Inc.
CARSON CITY, NV, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc., (OTC PINK: PHBI), today released a second management update form CEO Peter Wojcik. Today’s update provides further...
PHBI - Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset
December 02, 2021 09:36 ET
|
Pharmagreen Biotech, Inc.
Carson City, Nevada, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc., (OTC Pink: PHBI), today released a management update from CEO Peter Wojcik. The update is the first in a series of...
Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset
December 02, 2021 07:00 ET
|
Pharmagreen Biotech Inc.
CARSON CITY, NV, Dec. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), today released a management update from CEO Peter Wojcik. The update is the...
Pharmagreen Prepares for Entry Into the Multi-Billion Dollar California Cannabis Industry
November 11, 2021 07:30 ET
|
Pharmagreen Biotech Inc.
CARSON CITY, NV, Nov. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to announce that in advance of its entry into the multi-billion dollar...
Pharmagreen Submits Its Application for Uplisting to the OTCQB Venture Market
November 04, 2021 07:00 ET
|
Pharmagreen Biotech Inc.
CARSON CITY, NV, Nov. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), a specialized tissue cultured starter plantlet production company, targeting the...